A randomized, double-blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma

导出原文传递

翻译打印收藏纠错

作者： Kubo, Kohmei ^[1] ; Miyazaki, Yasuhiko ^[2] ; Murayama, Tohru ^[3] ; Shimazaki, Ryutaro ^[4] ; Usui, Noriko ^[5] ; Urabe, Akio ^[6] ; Hotta, Tomomitsu ^[7] ; Tamura, Kazuo ^[8]

作者单位： NTT Med Ctr, Tokyo, Japan ^[1] Jikei Univ, Daisan Hosp, Dept Clin Oncol & Haematol, Tokyo, Japan ^[2] Kyowa Hakko Kirin Co Ltd, R&D Div, Tokyo, Japan ^[3] Aomori Prefectural Cent Hosp, Dept Haematol, 2-1-1 Higashi, Aomori 0308553, Japan ^[4] Fukuoka Univ, Div Med Oncol Haematol & Infect Dis, Fukuoka, Japan ^[5] Natl Canc Ctr, Tokyo, Japan ^[6] Oita Prefectural Hosp, Dept Haematol, Oita, Japan ^[7] Hyogo Canc Ctr, Dept Haematol, Akashi, Hyogo, Japan ^[8]

关键词 pegfilgrastim CHASE(R) chemotherapy G-CSF febrile neutropenia malignant lymphoma

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交